↓ Skip to main content

Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany

Overview of attention for article published in BMC Complementary Medicine and Therapies, October 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany
Published in
BMC Complementary Medicine and Therapies, October 2013
DOI 10.1186/1472-6882-13-278
Pubmed ID
Authors

Sittah Czeche, Katrin Schüssel, Alexandra Franzmann, Martin Burkart, Martin Schulz

Abstract

Ginkgo biloba drugs (Gb) are reimbursed within the German statutory health insurance (SHI) scheme for treatment of dementia. In 2008, a novel Gb product containing 240 mg Ginkgo extract EGb761® per tablet was introduced aiming to facilitate medication use by incorporating the recommended daily dose in one single tablet. The aim of this study was to evaluate the relationship between dosage strength and persistence in a representative population of patients treated with Gb.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 25%
Researcher 5 21%
Student > Ph. D. Student 3 13%
Other 1 4%
Student > Doctoral Student 1 4%
Other 3 13%
Unknown 5 21%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Medicine and Dentistry 3 13%
Biochemistry, Genetics and Molecular Biology 2 8%
Nursing and Health Professions 2 8%
Psychology 2 8%
Other 4 17%
Unknown 7 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2015.
All research outputs
#20,246,428
of 22,774,233 outputs
Outputs from BMC Complementary Medicine and Therapies
#2,971
of 3,623 outputs
Outputs of similar age
#184,949
of 212,085 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#92
of 96 outputs
Altmetric has tracked 22,774,233 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,623 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,085 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.